Gilead's remdesivir reduces lung damage in monkeys with Covid-19
US drug-maker Gilead Sciences`s investigational anitiviral drug remdesivir reduced lung damage in rhesus macaque monkeys, said a study on Tuesday.
The study was carried out by Emmie de Wit from National Institute of Allergy and Infectious Diseases of the US National Institutes of Health and colleagues. Photo: Reuters